Action Adagene - ADAG

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

1,9499

Prix Achat

1,74

Prix Vente

2,11

Volume échangé

3 185

1,92 Fourchette du Jour 1,96

0,00 Plage de 52 semaines 0,00

Cap du marché

91,859M

Clôture Veille

1,905

Ouverture

1,96

Dernière Transaction

1.94

Dernière heure de transaction

22:00:00

Volume financier

US$ 6 183

VWAP

1,9414

Volume moyen (3 m)

Actions en circulation

47 109 555

Rendement du Dividende

Ratio Cours sur Bénéfices

-2,75

Bénéfice par action (BPA)

-0,71

Chiffre d'affairess

103k

Bénéfice net

-33,42M

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reacti... Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline. Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Siège social

Grand Cayman, Cym

Fondé

Adagene Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ADAG. Le dernier cours de clôture d'Adagene était de US$1,91. Au cours de la dernière année, les actions de Adagene ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Adagene compte actuellement 47 109 555 actions en circulation. La capitalisation boursière d'Adagene est de US$89,74 million. Adagene a un ratio cours/bénéfice (ratio PE) de -2.75.

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

ADAG - Frequently Asked Questions (FAQ)

What is the current Adagene share price?

The current share price of Adagene is US$ 1,9499

How many Adagene shares are in issue?

Adagene has 47 109 555 shares in issue

What is the market cap of Adagene?

The market capitalisation of Adagene is USD 89,74M

What is the 1 year trading range for Adagene share price?

Adagene has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of Adagene?

The price to earnings ratio of Adagene is -2,75

What is the cash to sales ratio of Adagene?

The cash to sales ratio of Adagene is 886,36

What is the reporting currency for Adagene?

Adagene reports financial results in USD

What is the latest annual turnover for Adagene?

The latest annual turnover of Adagene is USD 103k

What is the latest annual profit for Adagene?

The latest annual profit of Adagene is USD -33,42M

What is the registered address of Adagene?

The registered address for Adagene is P. O. BOX 31119 GRAND PAVILION, HIBISCUS WAY, 802 WEST BAY ROAD, GRAND CAYMAN, KY1 - 1205

Which industry sector does Adagene operate in?

Adagene operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
XTKGX3 Holdings Company Ltd	US$ 1,55 (21,09%)	262,21k
CFSBCFSB Bancorp Inc	US$ 15,11 (10,29%)	349
SRRKScholar Rock Holdings Corporation	US$ 36,78 (10,09%)	63,96k
MSPRMSP Recovery Inc	US$ 1,45 (9,85%)	25,71k
GNSSGenasys Inc	US$ 1,70 (9,32%)	310,05k
GVHGlobavend Holdings Ltd	US$ 0,97 (-22,41%)	34,82k
CIITTianci International Inc	US$ 1,80 (-15,89%)	1,46k
FBRXForte Biosciences Inc	US$ 12,50 (-11,79%)	15,65k
XTLBXTL Biopharmaceuticals Ltd	US$ 1,16 (-11,45%)	4,51k
CARVCarver Bancorp Inc New	US$ 1,5501 (-9,93%)	5,16k
GNLNGreenlane Holdings Inc	US$ 0,0082 (-8,89%)	23,5M
HCTIHealthcare Triangle Inc	US$ 0,0329 (-0,30%)	12,23M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 13,5499 (-0,51%)	6,81M
TNFATNF Pharmaceuticals Inc	US$ 0,1389 (-0,64%)	6,55M
NSPRInspireMD Inc New	US$ 2,3297 (-5,87%)	4,8M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Adagene Inc (ADAG)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Adagene Inc

ADAG Dernières nouvelles

Form EFFECT - Notice of Effectiveness

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form F-3 - Registration statement by foreign private issuers

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

Form EFFECT - Notice of Effectiveness

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form F-3 - Registration statement by foreign private issuers

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

ADAG - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Adagene Inc (ADAG) Cours

Adagene Inc (ADAG)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Adagene Inc

ADAG Dernières nouvelles

Form EFFECT - Notice of Effectiveness

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form F-3 - Registration statement by foreign private issuers

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

Form EFFECT - Notice of Effectiveness

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form F-3 - Registration statement by foreign private issuers

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

ADAG - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Connectez-vous

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR